Wegovy and Saggy Skin: What Actually Happens to Your Skin During Weight Loss

What the trial data tells us about weight loss at this scale

The STEP 1 clinical trial, published in the New England Journal of Medicine, followed 1,961 adults over 68 weeks. Participants using semaglutide 2.4 mg lost around 15% of their body weight on average. Some lost considerably more. That kind of reduction (often 10–20 kg or more depending on starting weight) is substantial enough that skin, which expanded gradually over years, does not always spring back at the same rate.

Skin elasticity is largely a function of collagen and elastin fibres. Both degrade with age and with prolonged stretching. When the fat beneath the skin reduces quickly, those fibres may not have sufficient time or biological capacity to tighten. The result is the loose, softer tissue many people notice around the belly, upper arms and inner thighs. This is not a side effect of semaglutide, it is a consequence of the weight loss itself, the same phenomenon seen after bariatric surgery or any substantial calorie-restricted programme. If anything, the more successful the treatment, the more visible the change in skin contour can be.

It is worth being honest about the frustration many people feel here: you've worked hard, you've lost meaningful weight, and then you're dealing with something you didn't expect. That is a completely reasonable reaction, and it is worth discussing openly with a clinician.

Why some people notice it more than others on semaglutide

Several factors determine how much loose skin appears after rapid weight loss. Age is the most significant: collagen production slows from the mid-twenties onwards, which means a 55-year-old losing 20 kg will typically see more laxity than a 28-year-old losing the same amount. Genetics play a role too, as does the total volume of weight lost, larger losses mean more stretched tissue to retract.

The pace of loss also matters. Semaglutide, because it significantly reduces appetite, can produce relatively fast early weight reduction, especially in the first three to four months. The NHS medicines information for semaglutide explains that the drug works partly by slowing gastric emptying and partly by acting on appetite-regulating centres in the brain, reducing calorie intake substantially. A slower, more gradual trajectory (which some people experience naturally as the dose stabilises) may give skin slightly more time to adapt, though there is no guarantee.

Smoking history, sun damage and prior significant weight fluctuations (repeated cycles of loss and gain) all reduce skin resilience further. None of these factors can be changed after the fact, but knowing them helps set realistic expectations before starting treatment.

Practical steps that support skin during weight loss

Clinical guidance consistently points to three areas that can make a meaningful difference. First, protein intake: muscle preservation matters both for metabolism and for maintaining the underlying tissue structure that gives skin something to sit against. Most weight-loss guidelines suggest adults losing weight aim for at least 1.2 g of protein per kilogram of body weight daily, though your prescriber or dietitian should advise on targets specific to you. Second, strength training, resistance exercise stimulates collagen synthesis and builds lean mass beneath the skin, which physically reduces the appearance of laxity. Third, hydration: well-hydrated skin retains more elasticity than chronically dehydrated skin.

Topical treatments marketed for skin tightening have a much weaker evidence base. Some contain ingredients like retinol or hyaluronic acid that support surface hydration, but no cream penetrates deeply enough to rebuild collagen at the level affected by major weight loss. For significant loose skin, particularly after losses of 25 kg or more, some people eventually discuss surgical options with a plastic surgeon, that is a separate clinical pathway entirely outside the scope of weight-loss treatment. If you are curious about how semaglutide affects skin more broadly, our page on Wegovy and skin health covers the wider picture, including injection-site reactions and dry skin.

There is also useful detail on the skin-related effects of semaglutide if you want to read further before your consultation. The connection between Wegovy and dry skin is a separate but related question worth reading if you have noticed skin texture changes alongside laxity. For those with injection-site discomfort, skin pain around Wegovy injection sites has its own dedicated page. If redness or irritation around the injection area is something you have experienced, our guide to managing sore skin with Wegovy explains what typically causes it and what you can do.

What this means for treatment decisions

Loose skin is not a reason to avoid treatment if your weight poses a genuine health risk, the cardiovascular, metabolic and joint-health benefits of sustained weight loss are well-established. But it is a reason to go in with realistic expectations and to plan your approach to lifestyle factors from the outset rather than retrospectively.

If you are weighing up which treatment might suit you, the overview on weight-loss treatment options sets out the licensed medicines available in the UK, including both semaglutide and tirzepatide, and how their results compare. Considering cost alongside everything else? The full Wegovy treatment guide includes a transparent cost context section. A prescriber at nume can discuss your individual circumstances, health history and goals during a free consultation, the same clinician who reviews your answers also makes the prescribing decision, with no algorithm in the loop. If you have questions before starting, our FAQs cover the most common ones, and the contact page connects you directly to our team. When you are ready, speak to our prescribers to find out whether Wegovy is right for you.